Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
KLF6
(Zf9, COPEB), an ubiquitous transcription factor, maps to chromosome 10p. Recently,
KLF6
was found to have a more generalized role in tumorigenesis as a candidate tumor suppressor gene for some tumors. However, results from other published studies seem not to be in agreement with data from previous studies. Gene-expression analysis is increasingly important in biological research. Loss of expression is one of the mechanisms to functionally inactivate a tumor suppressor gene. To investigate the expression change of
KLF6
gene associated with
HCC
as a step toward a better understanding of the molecular pathophysiology, and to provide the basis for analysis of
KLF6
gene in
HCC
carcinogenesis. We analyzed the expression of
KLF6
mRNA in 26 samples of
HCC
tissues and hepatoma cell lines(Hep3B and HepG2) detected by Real-Time quantitative RT-PCR (qRT-PCR) and conventional RT-PCR assay. To confirm and extend the data obtained at RNA level, we performed detailed immunoblotting analysis on
HCC
tissues and hepatoma cell lines using a rabbit polyclonal antibody specific for
KLF6
. NKLF6 detected by qRT-PCR from
HCC
and corresponding noncancerous tissues was 0.04+/-0.038 and 0.116+/-0.101, respectively. These data demonstrated that
KLF6
mRNA level was significantly decreased in
HCC
, compared with corresponding noncancerous tissues (t =3.683 , P<0.001). The frequency of Hepatoma Cell Lines with
KLF6
down-regulation detected by conventional PT-PCR, seems to be consistent with a previous study using real-time PCR assays in tumor samples.
KLF6
expression levels were determined by Western blot. Compared to the matched surrounding tissues, a clear decrease of
KLF6
protein levels in tumor tissues was observable (t=13.59, P<0.001). Hepatoma cell lines also showed low-level of
KLF6
protein (P<0.01) expression. Immunohistochemistry and immunocytochemistry showed a faint diffused staining in the
HCC
tissues and hepatoma cell lines, and endogenous
KLF6
protein was detected mostly in the cytoplasm.
KLF6
gene appeared markedly reduced in
HCC
tissues and hepatoma cell lines. Frequent down-regulation of
KLF6
strongly suggested that it is a candidate of tumor suppressor gene for
HCC
.
...
PMID:Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines. 1755 Jan 40
KLF6
is ubiquitously expressed in human tissues and regulates many pathways such as differentiation, development, cellular proliferation, growth-related signal transduction, and apoptosis. We previously demonstrated that
KLF6
expression is altered during liver carcinogenesis. More importantly,
KLF6
invalidation results in cell cycle progression inhibition and apoptosis of liver cancer cells. On the other hand, enforced expression of
KLF6
variant 2 (SV2) induces cancer cell death by apoptosis. Thus, we and others demonstrated that
KLF6
and its splicing variants play a critical role in liver cancer. However, little is known on the mechanisms governing
KLF6
expression in
HCC
. In the present work, we asked whether the 3' untranslated region (3'UTR) of the
KLF6
mRNA may be responsible for regulation of
KLF6
expression in
HCC
. We found that
KLF6
mRNA stability was altered in liver-derived cell lines as compared to cervical cancer-derived cell lines and human embryonic fibroblasts. Interestingly,
KLF6
mRNA was highly unstable in liver cancer-derived cell lines as compared to normal hepatocytes. We next cloned the
KLF6
mRNA 3'UTR into luciferase-expressing vectors and found that gene expression and activity were strongly impaired in all liver-derived cell lines tested. In addition, we found that most the
KLF6
3'UTR destabilisation activity resides between nt 1,835 and nt 2,615 of the
KLF6
gene. Taken together, we provide the first steps towards better understanding of the regulation of
KLF6
expression in
HCC
. Further work is needed to identify the factors that bind to
KLF6
3'UTR to regulate its expression in liver cancer-derived cell lines.
...
PMID:The Role of the 3' Untranslated Region in the Post-Transcriptional Regulation of KLF6 Gene Expression in Hepatocellular Carcinoma. 2437 51